PER percheron therapeutics limited

Ann: $13.0 million Institutional Placement, page-295

  1. 140 Posts.
    lightbulb Created with Sketch. 86
    My take on this sorry saga. The Board have lost sight of their duty to maximise s/h wealth. They are focussed on having sufficient cash to fund the continuance of the drug to trial participants. They are enamoured by the drug’s efficacy in treating DMD. We are LT shareholders who have taken a risk in investing in the drug and want to be compensated accordingly. We are at a crossroad with the current Board’s agenda.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $727 72.68K

Buyers (Bids)

No. Vol. Price($)
4 2840316 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3323423 6
View Market Depth
Last trade - 12.00pm 20/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.